TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Successful PVC suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LV recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Death and resuscitated cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: symptom severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity to detect high grade intraepithelial lesion (CIN 2+) or invasive cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Physical activity metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MIP (maximum inspiratory pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CRC screening receptivity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FIT Kit uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: confirmed SVR12
Endpoint domain: Mortality/survival
Primary endpoint: response of the injected wart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of acute mountain sickness (AMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of immunoglobulin (Ig)A and IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 2‐y progression‐free survival
Endpoint domain: Mortality/survival
Primary endpoint: Cotinine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of obstetric complications
Endpoint domain: Adverse events/effects
Primary endpoint: Usefulness of telemedicine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reported instrumental use
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Cell migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of salivary S. mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in plaque scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28‐CRP change from baseline at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: genitourinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of acute ischemic stroke/transient ischemic attack, acute myocardial infarction, and death from vascular causes
Endpoint domain: Mortality/survival
Primary endpoint: Stroke/transient ischemic attack events
Endpoint domain: Mortality/survival
Primary endpoint: Ankle-brachial index and pain-free walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mean visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications requiring resurgery
Endpoint domain: Adverse events/effects
Primary endpoint: Texture analysis features in renal tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Discriminatory value for cc-RCC diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cost savings
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: overall perioperative transfusion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Return to pre-injury sports
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean health and social care costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: An. funestus mortality
Endpoint domain: Mortality/survival
Primary endpoint: Pain-freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative dry eye indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of facial numbness
Endpoint domain: Adverse events/effects
Primary endpoint: Facial paralysis grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prognostic score (GOS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptoms of periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory markers in serum and GCF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic endotoxin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin D intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total visit duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Staffing costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 12-month HIV care retention rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month combined retention and viral suppression endpoint rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual angina after PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAQ‐7 summary scores at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in cosmetic results
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vocal Function Index (VFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice Handicap Index-30 (VHI-30)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resonant voice quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of participating in future trials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bayley-III scores at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Underwent meniscal surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Jefferson Scale of Physician Empathy (JSPE) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Planning times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision in planning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive development trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to achievement of selected gross motor milestones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of deep-enough compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time intervals of simulation start-to-first-compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resolution of micro-erosions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: resolution of RVP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: primary composite efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of wound healing events (WHEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Relative time within the prescribed HRR zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute PA time ≥40% of HRR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle mass improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Liver Frailty Index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: zinc levels increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ability to remember the correct name of the allergen
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total very-low-density lipoproteins (VLDLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Total low-density lipoproteins (LDLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Total high-density lipoproteins (HDLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Indexed left ventricular mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: satisfactory treatment of unilateral sympathectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: less compensatory sweating with two-stage bilateral sympathectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: birth weights
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of CXCL14 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New onset of perinatal major depressive episodes (MDE)
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of the PLAN intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Engagement with the intervention components
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: VAS scores of rest and activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scores of cold and dampness symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upright heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Δ heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: standing norepinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Quality of Life (QoL) total scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Low-density lipoprotein (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: non-work activity impairment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: overall work productivity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Severity of peak URTI symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days with URTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure pain threshold of the masseter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total score of FS-14
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: absolute correction error of TS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluoroscopy dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Extent of visceral pleural invasion
Endpoint domain: Mortality/survival
Primary endpoint: Intentions to refer Black and Latino patients to LCTs
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: catheter colonisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: vigilance task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: valid cues response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: invalid cues response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average filling time per bottle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MENQOL improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: LPS levels post-exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Daily activity level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: meal-stimulated GLP-1 secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: meal-stimulated glucagon secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cognitive function improvement (MMSE, MoCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor function improvement (ADL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Rankin scale (mRS) 0‐2 at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: final thrombolysis in cerebral infarction (TICI) 2b/3 rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial identification frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 5S Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean decrease of PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in size of the stone in left kidney
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ROS and MDA content in suspended red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOD and GSH-Px activity in suspended red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAT activity in suspended red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant change in analyte levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak gametocyte density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Population-level viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: severe perioperative bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of time in the euglycemic range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of time spent at <70 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of PCR-detectable Plasmodium infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in surgical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in time to complete the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recommendation for radial head replacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: percentage of weight loss at three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in fat mass measured by the fat mass index (FMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in lipid parameters, glycemic control, and systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FMA test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BBS test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMT test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial gait parameters (step length, walking speed, cadence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in weight-for-age z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sputum bacterial colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Post-treatment hs-CRP values ≤1.0 mg/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: prevalence of ZPP ≥ 80 µmol/mol heme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention capture of warnings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recall of warnings
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: requirement of oxygen support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in NT-Pro BNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: α-diversity of the fecal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cronbach's alpha for total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pooled overall accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RFD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMJ muscle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients without treatment failure at 9 months
Endpoint domain: Mortality/survival
Primary endpoint: Total and free fatty acids and related oxylipins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased on-study T2 lesion formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual percentage change of WB volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual percentage change of thalamic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe perioperative morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: R-MCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥ 2 GU and GI toxicity rates
Endpoint domain: Adverse events/effects
Primary endpoint: EORTC QLQ-PR25 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Non-VA acute care alert received
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: strut coverage rate (≥20 μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: uncoverage rate (0 μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in syndecan‐1 plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sealer penetration area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remaining sealer along the canal wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retreatment time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incremental costs per QALY saved
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of death or HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Bone Volume Variation (BVv)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of primary-outcome event
Endpoint domain: Mortality/survival
Primary endpoint: incidence of any preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: incidence of preterm birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Color changes (ΔE00)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clarity and emotional repair
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: negative mood measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: adaptive coping strategies
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: S100β levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MMSE and WMS scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cerebral hemodynamic indexes (rMTT, rTTP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric emptying T1/2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Colonic filling at 6h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 10% small bowel transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ACR/EULAR Boolean remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peristomal skin irritations
Endpoint domain: Adverse events/effects
Primary endpoint: Spin speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median delay in onset of T2DM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes